Rachel V Guest Selected Research

Carcinogenesis

10/2016

Notch3 drives development and progression of cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachel V Guest Research Topics

Disease

4	Cholangiocarcinoma 01/2022 - 03/2015
3	Neoplasms (Cancer) 01/2022 - 10/2016
2	Klatskin Tumor 12/2021 - 01/2021
2	Necrosis 01/2021 - 08/2015
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Pain (Aches) 01/2019
1	Gallstones (Gallstone) 01/2019
1	Carcinogenesis 10/2016
1	Liver Diseases (Liver Disease) 08/2015

Drug/Important Bio-Agent (IBA)

1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	locked nucleic acidIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Notch3 ReceptorIBA 10/2016
1	Immunoglobulins (Immunoglobulin)IBA 10/2016
1	Carrier Proteins (Binding Protein)IBA 10/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2015

Therapy/Procedure

3	Liver Transplantation 12/2021 - 08/2015
2	Therapeutics 01/2022 - 10/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 03/2015
1	Neoadjuvant Therapy 01/2021
1	Cholecystectomy 01/2019